(Q73543421)
Statements
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy (English)
F M Brennan
K A Browne
P A Green
J M Jaspar
R N Maini